Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2002
04/30/2002US6380221 Ortho-anthranilamide derivatives as anti-coagulants
04/30/2002US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages
04/30/2002US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal
04/30/2002US6380215 For prevention and/or treatment of diseases caused by thrombus formation such as arterial thrombosis, arterial sclerosis, ischemic heart diseases
04/30/2002US6380210 Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
04/30/2002US6380204 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist activity
04/30/2002US6380201 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists
04/30/2002US6380184 For increased production of wool, milk, and meat by treating animals with therapeutically effective amount of compound
04/30/2002US6380134 N-pyridyl herbicide compounds
04/30/2002US6379882 Exposing a primary culture of retinal ganglion cells to an oxygen/glucose deprivation challenge with and without a test compound; after an incubation period, measure the percentage of apoptotic cells
04/30/2002US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation
04/30/2002CA2246994C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)¬1,4|diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
04/30/2002CA2241827C Novel substituted 4-(1h-benzimidazol-2-yl)¬1,4|diazepanes useful for the treatment of allergic diseases
04/30/2002CA2131761C Crystals of pyridonecarboxylic acid derivative
04/25/2002WO2002033026A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors
04/25/2002WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
04/25/2002WO2002032897A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
04/25/2002WO2002032894A1 Substituted imidazoles useful in the treatment of inflammatory diseases
04/25/2002WO2002032893A2 Piperidine compounds as anti-allergic
04/25/2002WO2002032880A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/25/2002WO2002032879A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
04/25/2002WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance
04/25/2002WO2002032872A1 Nitrogenous aromatic ring compounds
04/25/2002WO2002032871A2 Compounds and methods for treating multidrug resistance
04/25/2002WO2002032869A2 Substituted heterocyclic compounds for treating multidrug resistance
04/25/2002WO2002032868A2 2-substituted heterocyclic compounds and their use in treating multidrug resistance
04/25/2002WO2002032864A1 Pharmaceutically active sulfanilide derivatives
04/25/2002WO2002032863A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/25/2002WO2002032861A2 Orally active salts with tyrosine kinase activity
04/25/2002WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
04/25/2002WO2002010137A3 Indazole derivatives as JNK inhibitors
04/25/2002WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
04/25/2002WO2001056552A3 Farnesyl protein transferase inhibitors for treating breast cancer
04/25/2002WO2001047913A3 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect
04/25/2002WO2001045687A3 Use of bioactive metabolites of gepirone for the treatment of psychological disorders
04/25/2002WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
04/25/2002US20020049329 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
04/25/2002US20020049328 Such as (R)-1-Cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis
04/25/2002US20020049327 Such as 7-(3-chlorophenyl)-9-((4-chlorophenyl)-1H-imidazol-1-ylmethyl)-2,3-dihydro -1H,5H-benzo(ij)quinolizin-5-one; for forming oncogenes for signalling transformation of tumor cells
04/25/2002US20020049323 Anxiolytic agents
04/25/2002US20020049322 Quinoline and quinazoline compounds useful in therapy
04/25/2002US20020049243 Pyrrolidine derivatives
04/25/2002US20020049235 Pyridylpyrrole compounds useful as interleukin-and tnf antagonists
04/25/2002US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy
04/25/2002US20020049222 Cyclopentyl modulators of chemokine receptor activity
04/25/2002US20020049220 Substituted azoles
04/25/2002US20020049212 Benzimidazole compounds and salts containing piperidine ring are useful in treatment or prevention or medical conditions selected from pain, and inflammatoy diseases; analgesics
04/25/2002US20020049211 Combination treatment for depression and anxiety
04/25/2002US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors
04/25/2002US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders
04/25/2002US20020049199 N-linked carbamates and ureas of heterocyclic thioesters
04/25/2002US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
04/25/2002US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist
04/25/2002US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
04/25/2002US20020049192 6-hydroxy-7-Piperidine-, azetidine- or pyrrolidine-substituted
04/25/2002US20020049148 Bleach catalyst and composition and method for bleaching a substrate
04/25/2002US20020049141 Method of combating undesired plant growth on cereals
04/25/2002US20020049135 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
04/25/2002DE10051321A1 New 2-(4-amino-piperidin-1-yl)-2-aryl-N-(phenylalkyl)-acetamides, are potent neurokinin antagonists, useful e.g. for treating allergic, inflammatory or central nervous system diseases
04/25/2002DE10050492A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis
04/25/2002DE10050490A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis
04/25/2002CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis
04/25/2002CA2426337A1 Substituted imidazoles useful in the treatment of inflammatory diseases
04/25/2002CA2426271A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
04/25/2002CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/25/2002CA2424689A1 Orally active salts with tyrosine kinase activity
04/25/2002CA2423933A1 Pharmaceutically active sulfanilide derivatives
04/25/2002CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
04/25/2002CA2422717A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/25/2002CA2422655A1 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors
04/24/2002EP1199306A1 Biarylurea derivatives
04/24/2002EP1199070A2 Use of PDE V inhibitors for improved fecundity in mammals
04/24/2002EP1198456A2 Potassium channel openers
04/24/2002EP1198234A2 Bicyclic aromatic compounds for treating drug addiction
04/24/2002EP1180366A9 Neuronal death inhibitors
04/24/2002EP0782568B1 Aromatic ethers derived from indols such as 5ht1-like ligands
04/24/2002EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
04/24/2002CN1346355A Novel inhibitors of farnesyl-protein transferase
04/24/2002CN1346354A Substituted benzoylpyrazoles as herbicides
04/24/2002CN1346353A Farnesy transferase inhibitors having a pyrrole structure and process for preparation thereof
04/24/2002CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4
04/24/2002CN1346348A Amide compounds and medicinal use thereof
04/24/2002CN1346347A Cyclic amine derivatives and uses thereof
04/24/2002CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia
04/24/2002CN1346271A Quinazoline derivatives as angiogenesis inhibitors
04/24/2002CN1345724A Indolylpiperidine compound and preparation process and use thereof
04/24/2002CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators
04/24/2002CN1083437C 2-[1',2',4'-triazol-3'-yloxymethylenel anilides,] their preparation and use
04/24/2002CN1083433C Herbicidal heterocyclic-substituted pyridines, its preparation and herbicidal composition and use
04/24/2002CN1083432C Process for preparing amine compound and its salt
04/24/2002CN1083431C Novel heterocyclic compounds
04/23/2002US6376672 Restenosis; vision defects; cardiovascular disorders; kidney dieases
04/23/2002US6376670 Bactericide for grampositive bacteria
04/23/2002US6376668 Reacting pyridinecarbonitrile compound with potassium hydroxide in butanol; hydrolysis
04/23/2002US6376667 Cyclization in presenc eof base
04/23/2002US6376665 Antiarthritic agents, antiinflammatory agents
04/23/2002US6376656 Disazo dyes, triazine dyes
04/23/2002US6376584 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith
04/23/2002US6376548 Enhanced propertied pesticides
04/23/2002US6376527 Pyrazole derivatives-p38 map kinase inhibitors